Steven E Lindley1, Eve B Carlson, Maryse Benoit. 1. Department of Veterans Affairs, National Center for Posttraumatic Stress Disorder, Palo Alto Veterans Affairs Health Care System, Menlo Park, California 94025, USA.
Abstract
BACKGROUND: Posttraumatic stress disorder (PTSD) has been associated with lower concentrations of cortisol and enhanced suppression of cortisol by dexamethasone, although discrepancies exist among reports. The objective of the study was to determine the pattern of cortisol responses in patients seeking treatment for PTSD resulting from a variety of traumatic experiences and to test whether cortisol responses are significantly related to childhood trauma, severity of symptoms, or length of time since trauma. METHODS: Salivary cortisol was measured at 8 AM, 4 PM, and 10 PM on 2 consecutive days before and after a 10 PM dose of .5 mg dexamethasone in 17 psychotropic medication and substance-free subjects with PTSD and 17 matched control subjects. RESULTS: Repeated-measures analysis of variance (ANOVA) of the baseline salivary cortisol concentrations demonstrated a significant effect for group with higher concentrations in the PTSD group but no significant differences in responses to dexamethasone. The presence of childhood abuse did not significantly affect salivary cortisol concentrations, and there was no correlation between predexamethasone cortisol and either the severity of PTSD symptoms or the time since the index trauma. CONCLUSIONS: Neither low basal concentrations nor enhanced suppression of cortisol are consistent markers of a PTSD diagnosis.
BACKGROUND:Posttraumatic stress disorder (PTSD) has been associated with lower concentrations of cortisol and enhanced suppression of cortisol by dexamethasone, although discrepancies exist among reports. The objective of the study was to determine the pattern of cortisol responses in patients seeking treatment for PTSD resulting from a variety of traumatic experiences and to test whether cortisol responses are significantly related to childhood trauma, severity of symptoms, or length of time since trauma. METHODS: Salivary cortisol was measured at 8 AM, 4 PM, and 10 PM on 2 consecutive days before and after a 10 PM dose of .5 mg dexamethasone in 17 psychotropic medication and substance-free subjects with PTSD and 17 matched control subjects. RESULTS: Repeated-measures analysis of variance (ANOVA) of the baseline salivary cortisol concentrations demonstrated a significant effect for group with higher concentrations in the PTSD group but no significant differences in responses to dexamethasone. The presence of childhood abuse did not significantly affect salivary cortisol concentrations, and there was no correlation between predexamethasone cortisol and either the severity of PTSD symptoms or the time since the index trauma. CONCLUSIONS: Neither low basal concentrations nor enhanced suppression of cortisol are consistent markers of a PTSD diagnosis.
Authors: Carlo Faravelli; Carolina Lo Sauro; Lucia Godini; Lorenzo Lelli; Laura Benni; Francesco Pietrini; Lisa Lazzeretti; Gabriela Alina Talamba; Giulia Fioravanti; Valdo Ricca Journal: World J Psychiatry Date: 2012-02-22
Authors: Eric Vermetten; Meena Vythilingam; Christian Schmahl; Carien DE Kloet; Steven M Southwick; Dennis S Charney; J Douglas Bremner Journal: Ann N Y Acad Sci Date: 2006-07 Impact factor: 5.691
Authors: Lívia Maria Bolsoni; Thiago Dornela Apolinário da Silva; Silvana Maria Quintana; Margaret de Castro; José Alexandre Crippa; Antonio Waldo Zuardi Journal: Perm J Date: 2019-09-27
Authors: Linda J Metzger; Margaret A Carson; Natasha B Lasko; Lynn A Paulus; Scott P Orr; Roger K Pitman; Rachel Yehuda Journal: Psychiatry Res Date: 2008-10-25 Impact factor: 3.222
Authors: Allen D Radant; Dorcas J Dobie; Elaine R Peskind; M Michele Murburg; Eric C Petrie; Evan D Kanter; Murray A Raskind; Charles W Wilkinson Journal: Front Behav Neurosci Date: 2009-10-30 Impact factor: 3.558